{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:09:04Z","timestamp":1787504944182,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Instituto de Salud Carlos III and FEDER","award":["PI20\/01495"],"award-info":[{"award-number":["PI20\/01495"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The EORTC Quality of Life Group recently developed the new version of its breast-cancer-specific quality of life questionnaire, the EORTC QLQ-BR42. This questionnaire updates EORTC QLQ-BR23, which was published in 1996. Since then, significant changes have occurred in breast cancer treatment. The aims of this study were to evaluate the psychometric properties of the QLQ-BR42 in Spanish breast cancer patients and compare the results with those of the EORTC international validation study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis of QLQ-BR42 data from three Spanish breast cancer patient cohorts was conducted to evaluate the questionnaire\u2019s psychometric properties, including scale structure, internal consistency, test-retest reliability, validity (convergent, discriminant, known-groups), and responsiveness to change. The three cohorts comprised, respectively, patients in stages I-III undergoing endocrine treatment, patients with metastatic disease, and patients in stages I-III diagnosed with COVID-19. The metastatic and COVID-19 cohorts completed the EORTC QLQ-BR42 and the EORTC QLQ-C30 once each, while the endocrine treatment cohort completed the questionnaires three times.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 516 patients were included in the study (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009159 in the endocrine treatment cohort,\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200998 in the metastatic patients cohort and\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009259 in the COVID-19 cohort). Confirmatory factor analyses generally supported the structure of all scales included (RMSEA\u2009=\u20090.051).\n                    <\/jats:p>\n                    <jats:p>Factor loadings were above 0.60, except for the systemic chemotherapy side effects (SCSE) scale, which includes three items with factor loadings ranging from 0.29 to 0.41.<\/jats:p>\n                    <jats:p>\n                      Correlations with (un)related QLQ-C30 scales supported convergent validity (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009&gt;\u20090.40) and discriminant validity (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009&lt;\u20090.10). The QLQ-BR42 scales distinguished between stage I-III patients who received endocrine treatment and those with metastatic disease, as well as between surgical approaches. Substantial changes over time were observed in patients whose global QOL (measured with QLQ-C30 item #30) had improved or worsened.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The EORTC QLQ-BR42 is a reliable and valid tool when used with a sample of Spanish breast cancer patients, although the SCSE requires further research on its internal consistency. These findings generally match those of the EORTC international validation study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-15831-8","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T11:04:20Z","timestamp":1773486260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The EORTC updated breast cancer quality of life questionnaire EORTC QLQ-BR42: A psychometric study with Spanish patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Juan Ignacio","family":"Arraras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Juan","family":"Illarramendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Manterola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M","family":"Giesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"de la Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Teijeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angels","family":"Pont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Bjelic-Radisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Lecumberri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Fernandez de Lascoiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"15831_CR1","unstructured":"REDECAN \u2013 Red. Espa\u00f1ola de Registros de C\u00e1ncer. https:\/\/www.redecan.org."},{"key":"15831_CR2","doi-asserted-by":"crossref","unstructured":"Barnadas A, Algara M, Cordoba O, Casas A, Gonzalez M, Marzo M, et al. Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM),Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology(SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC). Clin Transl Oncol. 2018;20(6):687\u2009\u2013\u200994.","DOI":"10.1007\/s12094-017-1801-4"},{"key":"15831_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12905-022-02153-7","volume":"23","author":"JH Park","year":"2023","unstructured":"Park JH, Jung YS, Kim JY, Bae SH. Trajectories of quality of life in breast cancer survivors during the first year after treatment: a longitudinal study. BMC Women\u2019s Health. 2023;23:12.","journal-title":"BMC Women\u2019s Health"},{"key":"15831_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"385","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;385:365\u201376.","journal-title":"J Natl Cancer Inst"},{"key":"15831_CR5","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1200\/JCO.1996.14.10.2756","volume":"14","author":"MA Sprangers","year":"1996","unstructured":"Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, et al. The European organisation for research and treatment of cancer: breast cancer specific quality of life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14:2756\u201368.","journal-title":"J Clin Oncol"},{"key":"15831_CR6","first-page":"81","volume":"9","author":"JI Arraras","year":"2001","unstructured":"Arraras JI, Tejedor M, Illarramendi JJ, Vera R, Pruja E, Marcos M, et al. El cuestionario de calidad de vida para c\u00e1ncer de mama de la EORTC, QLQ-BR23. Estudio psicom\u00e9trico con una muestra espa\u00f1ola. Psic Conduc. 2001;9:81\u201398.","journal-title":"Psic Conduc"},{"key":"15831_CR7","first-page":"329","volume":"11","author":"J Arraras","year":"2000","unstructured":"Arraras J, Garrido E, Pruja E, Marcos M, Tejedor M, Arias F. The EORTC Quality of Life questionnaire QLQ-C30 (2.0 Version). Psychometric study with breast cancer patients. Clin Salud. 2000;11:329\u201349.","journal-title":"Clin Salud"},{"key":"15831_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-023-01805-y","volume":"22","author":"F Ye","year":"2023","unstructured":"Ye F, Dewanjee S, Li Y, Jha NK, Chen ZS, Kumar A, et al. Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Mol Cancer. 2023;22:105.","journal-title":"Mol Cancer"},{"key":"15831_CR9","doi-asserted-by":"publisher","first-page":"188593","DOI":"10.1016\/j.bbcan.2021.188593","volume":"1876","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Zhu X, Tang C, Guan X, Zhang W. Progress and challenges of immunotherapy in triple-negative breast cancer. Biochim Biophys Acta Rev Cancer. 2021;1876:188593.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"15831_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2174\/0115680096289260240311062343","volume":"25","author":"A Debnath","year":"2025","unstructured":"Debnath A, Mazumder R. Clinical Progress of Targeted Therapy for Breast Cancer: A Comprehensive Review. Curr Cancer Drug Targets. 2025;25:555\u201373.","journal-title":"Curr Cancer Drug Targets"},{"issue":"5","key":"15831_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa2104162","volume":"385","author":"M Gnant","year":"2021","unstructured":"Gnant M, Fitzal F, Rinnerthaler G, Steger GG, Greil-Ressler S, Balic M, et al. Austrian Breast and Colorectal Cancer Study Group. Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer. N Engl J Med. 2021;385(5):395\u2013405.","journal-title":"N Engl J Med"},{"issue":"10262","key":"15831_CR12","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/S0140-6736(20)32323-0","volume":"396","author":"M Douek","year":"2020","unstructured":"Douek M, De Silva-Minor S, Davies L, Jones B. Breast cancer radiation therapy. Lancet. 2020;396(10262):1558\u20139.","journal-title":"Lancet"},{"key":"15831_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.annonc.2019.10.027","volume":"31","author":"V Bjelic-Radisic","year":"2020","unstructured":"Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, et al.. EORTC Quality of Life Group and Breast Cancer Group. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45. Ann Oncol. 2020;31:283\u20138.","journal-title":"Ann Oncol"},{"key":"15831_CR14","doi-asserted-by":"publisher","first-page":"103890","DOI":"10.1016\/j.breast.2025.103890","volume":"80","author":"V Bjelic-Radisic","year":"2025","unstructured":"Bjelic-Radisic V, Cardoso F, Weis J, Pogoda K, Arraras JI, Greimel E, et al. An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42. Breast. 2025;80:103890.","journal-title":"Breast"},{"key":"15831_CR15","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/annonc\/mdz298","volume":"30","author":"AR Ferreira","year":"2019","unstructured":"Ferreira AR, Di Meglio A, Pistilli B, Gbenou AS, El-Mouhebb M, Dauchy S, et al. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis. Ann Oncol. 2019;30:1784\u201395.","journal-title":"Ann Oncol"},{"key":"15831_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/GME.0000000000002178","volume":"30","author":"JI Arraras","year":"2023","unstructured":"Arraras JI, Illarramendi JJ, Manterola A, de la Cruz S, Zarandona U, Iba\u00f1ez B, et al. Quality of life in Spanish postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study. Menopause. 2023;30:613\u201320.","journal-title":"Menopause"},{"issue":"4","key":"15831_CR17","first-page":"350","volume":"28","author":"JI Arraras","year":"2024","unstructured":"Arraras JI, Illarramendi JJ, Manterola A, Zarandona U, Iba\u00f1ez B, Bottomley A, et al. Quality of life of patients treated for stage IV breast cancer. Multidimensional assessment and examination of determining factors. Contemp Oncol (Pozn). 2024;28(4):350\u20137.","journal-title":"Contemp Oncol (Pozn)"},{"issue":"5","key":"15831_CR18","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/pon.6118","volume":"32","author":"JI Arraras","year":"2023","unstructured":"Arraras JI, Illarramendi JJ, Manterola A, Cruz S, Zarandona U, Iba\u00f1ez B, et al. Quality of life of early-stage breast-cancer patients diagnosed with COVID-19 in the first three waves of the epidemic treated in the Spanish region of Navarre. Psychooncology. 2023;32(5):730\u201340.","journal-title":"Psychooncology"},{"key":"15831_CR19","volume-title":"EORTC Quality of Life Group translation procedure","author":"D Kuli\u015b","year":"2017","unstructured":"Kuli\u015b D, Bottomley A, Velikova G, Greimel E, Koller M. EORTC Quality of Life Group translation procedure. 4th ed. Brussels: EORTC QL Group; 2017.","edition":"4"},{"key":"15831_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"15831_CR21","first-page":"191","volume-title":"Evaluation of Chemotherapeutic Agents","author":"DA Karnofsky","year":"1949","unstructured":"Karnofsky DA, Burchenal JH. The evaluation of chemotherapeutic agents in cancer. In: McLeod CM, editor. Evaluation of Chemotherapeutic Agents. New York: University; 1949. pp. 191\u2013205."},{"key":"15831_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1287\/isre.8.4.342","volume":"8","author":"WW Chin","year":"1997","unstructured":"Chin WW, Gopal A, Salisbury WD. Inf Syst Res. 1997;8:342\u201367.","journal-title":"Inf Syst Res"},{"key":"15831_CR23","volume-title":"Multivariate Data Analysis","author":"JF Hair","year":"2010","unstructured":"Hair JF, Black WC, Babin BJ, Anderson RE. Multivariate Data Analysis. 7th ed. New York: Pearson; 2010.","edition":"7"},{"key":"15831_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10705519909540118","volume":"6","author":"L Hu","year":"1996","unstructured":"Hu L, Bentler P. Cut-off criteria for fit indices in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model. 1996;6:1\u201355.","journal-title":"Struct Equ Model"},{"key":"15831_CR25","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s11136-018-1829-0","volume":"27","author":"CB Terwee","year":"2018","unstructured":"Terwee CB, Prinsen CAC, Chiarotto A, Westerman MJ, Patrick DL, Alonso J, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res. 2018;27:1159\u201370.","journal-title":"Qual Life Res"},{"key":"15831_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF01593882","volume":"4","author":"CA McHorney","year":"1995","unstructured":"McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4:293\u2013307.","journal-title":"Qual Life Res"},{"key":"15831_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3758\/BF03203140","volume":"22","author":"RD Hays","year":"1990","unstructured":"Hays RD, Hayashi T. Beyond internal consistency reliability: rationale and user\u2019s guide for Multitrait Analysis Program on the microcomputer. Behav Res Meth Instrum Comput. 1990;22:167\u201375.","journal-title":"Behav Res Meth Instrum Comput"},{"key":"15831_CR28","volume-title":"Psychometric Theory","author":"JC Nunnally","year":"1994","unstructured":"Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed. New York: McGraw-Hill; 1994.","edition":"3"},{"key":"15831_CR29","unstructured":"Kline RB. Principles and Practice of Structural Equation Modeling. 4th ed. New York : Guilford Press; 2016."},{"key":"15831_CR30","volume-title":"Using Multivariate Statistics","author":"BG Tabachnick","year":"2013","unstructured":"Tabachnick BG, Fidell LS. Using Multivariate Statistics. 6th ed. Boston: MA: Pearson; 2013.","edition":"6"},{"key":"15831_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13104-016-2034-2","volume":"19","author":"IL Abma","year":"2016","unstructured":"Abma IL, Rovers M, van der Wees PJ. Appraising convergent validity of patient-reported outcome measures in systematic reviews: constructing hypotheses and interpreting outcomes. BMC Res Notes. 2016;19:226.","journal-title":"BMC Res Notes"},{"key":"15831_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/9780470024522","volume-title":"Quality of Life: The Assessment, Analysis and Interpretation of Patient-Reported Outcomes","author":"P Fayers","year":"2007","unstructured":"Fayers P, Machin D. Quality of Life: The Assessment, Analysis and Interpretation of Patient-Reported Outcomes. 2nd ed. Chichester; Hoboken, NJ: Wiley; 2007.","edition":"2"},{"key":"15831_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.breast.2018.03.002","volume":"39","author":"F Cardoso","year":"2018","unstructured":"Cardoso F, Spence D, Mertz S, Corneliussen-James D, Sabelko K, Gralow J, et al. Global analysis of advanced\/ metastatic breast cancer: decade report (2005\u20132015). Breast. 2018;39:131\u20138.","journal-title":"Breast"},{"key":"15831_CR34","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00432-008-0418-y","volume":"134","author":"V Arndt","year":"2008","unstructured":"Arndt V, Stegmaier C, Ziegler H, Brenner H. Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based study. J Cancer Res Clin Oncol. 2008;134:1311\u20138.","journal-title":"J Cancer Res Clin Oncol"},{"key":"15831_CR35","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing. 2023. URL. https:\/\/www.R-project.org\/."},{"key":"15831_CR36","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1037\/1040-3590.6.4.284","volume":"6","author":"DV Cicchetti","year":"1994","unstructured":"Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess. 1994;6:284\u201390.","journal-title":"Psychol Assess"},{"key":"15831_CR37","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates,; 1988.","edition":"2"},{"key":"15831_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-025-03962-6","author":"JI Arraras","year":"2025","unstructured":"Arraras JI, Illarramendi JJ, Manterola A, de la Cruz S, Teijeira L, Pont A, et al. Quality of life in very long-term (including\u2009>\u200920 years\u2019 follow-up) early-stage breast cancer survivors from Spain. Clin Transl Oncol. 2025. https:\/\/doi.org\/10.1007\/s12094-025-03962-6.","journal-title":"Clin Transl Oncol"},{"key":"15831_CR39","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s12094-019-02048-4","volume":"21","author":"JI Arraras","year":"2019","unstructured":"Arraras JI, Illarramendi JJ, Manterola A, Asin G, Salgado E, Arrondo P, et al. Quality of life in elderly breast cancer patients with localized disease receiving endocrine treatment: a prospective study. Clin Transl Oncol. 2019;21:1231\u20139.","journal-title":"Clin Transl Oncol"},{"key":"15831_CR40","doi-asserted-by":"publisher","first-page":"111301","DOI":"10.1016\/j.radonc.2025.111301","volume":"214","author":"S Ng","year":"2026","unstructured":"Ng S, Kirby AM, Kilburn LS, Griffin C, Sydenham M, Lloyd L, et al. Baseline characteristics predicting lower return rates of missing patient-reported quality of life data over 5 years: evidence from the IMPORT HIGH and IMPORT LOW breast cancer radiotherapy trials. Radiother Oncol. 2026;214:111301.","journal-title":"Radiother Oncol"},{"issue":"1","key":"15831_CR41","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1186\/s12905-025-04063-w","volume":"25","author":"M Besculides","year":"2025","unstructured":"Besculides M, Carney L, Gorbenko K, Green S, Brito M, Lynch J, et al. Sexual activity and functioning after breast cancer treatment: perspectives on the importance of pleasure from a radiotherapy cohort. BMC Womens Health. 2025;25(1):522. https:\/\/doi.org\/10.1186\/s12905-025-04063-w.","journal-title":"BMC Womens Health"},{"key":"15831_CR42","doi-asserted-by":"crossref","unstructured":"Pearson A, Dhillon HM, Chen J, Campbell R, Lombard J, Hickey M, et al. Genitourinary symptoms in women with breast cancer: frequency, severity and impact. Support Care Cancer. 2025;10;33:258.","DOI":"10.1007\/s00520-025-09297-w"},{"key":"15831_CR43","doi-asserted-by":"publisher","unstructured":"Kim Y, Min HY, An HJ. Fear of cancer recurrence interventions for breast cancer survivors in the 2020s: a systematic review. J Cancer Surviv. 2025;25. https:\/\/doi.org\/10.1007\/s11764-025-01774-9.","DOI":"10.1007\/s11764-025-01774-9"},{"issue":"1","key":"15831_CR44","doi-asserted-by":"publisher","first-page":"e13694","DOI":"10.1002\/jcsm.13694","volume":"16","author":"MS Khan","year":"2025","unstructured":"Khan MS, Butler J, Anker M. Weight Gain Among Cancer Patients Receiving Chemotherapy-Facts and Numbers. J Cachexia Sarcopenia Muscle. 2025;16(1):e13694.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"15831_CR45","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12282-021-01287-0","volume":"29","author":"ATPM Brands-Appeldoorn","year":"2022","unstructured":"Brands-Appeldoorn ATPM, Maaskant-Braat AJG, Janssen L, van Osch LADM, Tjan- Heijnen VCG, et al. Breast cancer patient-reported outcome of factors influencing cosmetic satisfaction after breast-conserving therapy. Breast Cancer. 2022;29(1):114\u201320.","journal-title":"Breast Cancer"},{"key":"15831_CR46","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/jjco\/hyx099","volume":"47","author":"HY Tsai","year":"2017","unstructured":"Tsai HY, Kuo RN, Chung KP. Quality of life of breast cancer survivors following breast-conserving therapy versus mastectomy: a multicenter study in Taiwan. Jpn J Clin Oncol. 2017;47:909\u201318.","journal-title":"Jpn J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15831-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15831-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15831-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:07:31Z","timestamp":1781640451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15831-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15831"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15831-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All three studies were approved by the Regional Ethics Committee for Biomedical Research of Navarra under projects 2018\/64, PI_2020\/106, and 2019\/57, respectively, and conducted in accordance with the Declaration of Helsinki. All patients signed written informed consent forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"522"}}